How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice Experiment

BACKGROUND: Because immunizing large numbers of healthy people could be required to reduce a relatively small number of infections, disease incidence has a large impact on cost effectiveness, even if the infection is associated with very serious health outcomes. In addition to cost effectiveness, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, F. Reed, Fairchild, Angelyn, Whittington, Dale, Srivastava, Amit K., Gonzalez, Juan Marcos, Huang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744670/
https://www.ncbi.nlm.nih.gov/pubmed/36509960
http://dx.doi.org/10.1007/s40271-022-00602-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744670/
https://www.ncbi.nlm.nih.gov/pubmed/36509960
http://dx.doi.org/10.1007/s40271-022-00602-x

Ejemplares similares